Consideration in Treatment Selection and Sequencing in R/R MM

The panel discusses how they approach treatment selection and sequencing for patients with relapsed/refractory multiple myeloma.

EP: 1.Clinical Scenario 1: A 67-Year-Old Man with Multiple Myeloma

EP: 2.Treatment Options in Late-line R/R MM Patients

EP: 3.Sequencing Options of Bispecifics in R/R MM

EP: 4.Pooled Analysis from MagnetisMM Studies

Now Viewing

EP: 5.Consideration in Treatment Selection and Sequencing in R/R MM

EP: 6.Clinical Scenario 2: A 70-Year-Old Male with R/R MM

Recent Videos